A detailed history of Intrinsic Edge Capital Management LLC transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Intrinsic Edge Capital Management LLC holds 100,000 shares of CDMO stock, worth $1.12 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
100,000
Holding current value
$1.12 Million
% of portfolio
0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.34 - $9.28 $634,000 - $927,999
100,000 New
100,000 $714,000
Q4 2021

Feb 14, 2022

SELL
$20.7 - $34.18 $4.16 Million - $6.87 Million
-200,866 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$18.93 - $25.65 $378,600 - $513,000
-20,000 Reduced 9.06%
200,866 $5.15 Million
Q1 2021

May 17, 2021

SELL
$11.86 - $21.77 $1.96 Million - $3.59 Million
-165,100 Reduced 42.78%
220,866 $4.03 Million
Q4 2020

Feb 16, 2021

BUY
$7.25 - $11.76 $2.8 Million - $4.54 Million
385,966 New
385,966 $4.45 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $694M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Intrinsic Edge Capital Management LLC Portfolio

Follow Intrinsic Edge Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrinsic Edge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrinsic Edge Capital Management LLC with notifications on news.